Surescripts LLC, Arlington, Virginia, USA.
Clinical Informatics, Yale New Haven Health System, New Haven, Connecticut, USA.
J Am Med Inform Assoc. 2018 Nov 1;25(11):1516-1523. doi: 10.1093/jamia/ocy100.
To illustrate the need for wider implementation of the CancelRx message by quantifying and characterizing the inappropriate usage of new electronic prescription (NewRx) messages for communicating discontinuation instructions to pharmacies.
A retrospective analysis on a nationally representative random sample of 1 400 000 NewRx messages transmitted over 7 days to identify e-prescriptions containing medication discontinuation instructions in NewRx text fields. A vocabulary of search terms signifying cancellation instructions was formulated and then iteratively refined. True-positives were subsequently identified programmatically and through manual reviews. Two independent reviewers identified incidences in which these instructions were associated with high-alert or look-alike-sound-like (LASA) medications.
We identified 9735 (0.7% of the total) NewRx messages containing prescription cancellation instructions with 78.5% observed in the Notes field; 35.3% of identified NewRxs were associated with high-alert or LASA medications. The most prevalent cancellation instruction types were medication strength or dosage changes (39.3%) and alternative therapy replacement orders (39.0%).
While the incidence of prescribers using the NewRx to transmit cancellation instructions was low, their transmission in NewRx fields not intended to accommodate such information can produce significant potential patient safety concerns, such as duplicate or inaccurate therapies. These findings reveal the need for wider industry adoption of the CancelRx message by electronic health record (EHR) and pharmacy systems, along with clearer guidance and improved end-user training, particularly as states increasingly mandate electronic prescribing of controlled substances.
Encouraging the use of CancelRx and reducing the misuse of NewRx fields would reduce workflow disruptions and unnecessary risks to patient safety.
通过量化和描述新电子处方(NewRx)消息用于向药房传达停药医嘱的不当使用情况,说明更广泛地实施 CancelRx 消息的必要性。
对全国代表性的随机抽取的 140 万例新电子处方消息进行回顾性分析,以确定 NewRx 文本字段中包含停药医嘱的电子处方。制定了一个表示取消医嘱的搜索词词汇,并进行了迭代优化。然后通过程序和手动审查来识别真正的阳性病例。两名独立的审查员确定了这些医嘱与高警示或类似音似形药物(LASA)药物相关的情况。
我们确定了 9735 条(占总数的 0.7%)NewRx 消息包含处方取消医嘱,其中 78.5%在 Notes 字段中观察到;35.3%识别出的 NewRxs 与高警示或 LASA 药物有关。最常见的取消医嘱类型是药物强度或剂量变化(39.3%)和替代治疗替代医嘱(39.0%)。
虽然使用 NewRx 发送取消医嘱的开方者的发生率较低,但将此类信息传输到不打算容纳此类信息的 NewRx 字段中可能会产生重大潜在的患者安全问题,例如重复或不准确的治疗。这些发现表明需要更广泛地采用电子健康记录(EHR)和药房系统的 CancelRx 消息,并提供更清晰的指导和改进的最终用户培训,特别是随着各州越来越多地要求电子处方管制药物。
鼓励使用 CancelRx 并减少对 NewRx 字段的滥用,将减少工作流程中断和对患者安全的不必要风险。